Cytotoxicity and antitumor activity of the phosphate prodrug of a novel microtubule inhibitor.

被引:0
|
作者
Houze, J [1 ]
Gergely, J [1 ]
Schwendner, S [1 ]
Hoffman, L [1 ]
Beckmann, H [1 ]
Baichwal, V [1 ]
Roche, D [1 ]
Jaen, J [1 ]
机构
[1] Tularik Inc, S San Francisco, CA 94080 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
635
引用
收藏
页码:3857S / 3857S
页数:1
相关论文
共 50 条
  • [41] A-87049, a novel potent squalene synthase inhibitor.
    Fung, AKL
    Baker, WR
    Fakhoury, S
    Stein, HH
    Cohen, J
    Donner, BG
    Garvey, DS
    Spina, KP
    Rosenberg, SH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 137 - MEDI
  • [42] Erratum to: Cabazitaxel: a novel microtubule inhibitor
    C Villanueva
    F. Bazan
    S Kim
    Drugs, 2011, 71 (13) : 1720 - 1720
  • [43] Fosamprenavir - A novel protease inhibitor and prodrug of amprenavir
    Ellis, JM
    Ross, JW
    Coleman, CI
    FORMULARY, 2004, 39 (03) : 151 - +
  • [44] Evaluation of the antitumor activity of NOV202, a novel microtubule targeting and vascular disrupting agent
    Rickardson, Linda
    Kutvonen, Emma
    Orasniemi, Satu
    Hogberg, Marita
    Kallio, Marko J.
    Rehnmark, Stefan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 1335 - 1351
  • [45] In Vitro Cytotoxicity and In Vivo Antitumor Activity of Lipid Nanocapsules Loaded with Novel Pyridine Derivatives
    Abu Lila, Amr Selim
    Amran, Mohammed
    Tantawy, Mohamed A.
    Moglad, Ehssan H.
    Gad, Shadeed
    Alotaibi, Hadil Faris
    Obaidullah, Ahmad J.
    Khafagy, El-Sayed
    PHARMACEUTICS, 2023, 15 (06)
  • [47] Modulation of Adriamycin cytotoxicity and antitumor activity by proanthocyanidins
    Bogdanovic, GM
    Kojic, V
    Brunet, JC
    Vuckovic, D
    Kovac, V
    Kovacevic, ZL
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 436 - 436
  • [48] Enhanced antitumor activity of microtubule polymerization inhibitors by polymethoxyflavones
    Ito, Kazuha
    Iwasawa, Takumi
    Yonezawa, Takayuki
    Watanabe, Akio
    Woo, Jetae
    Kato, Kazunori
    CANCER SCIENCE, 2022, 113 : 701 - 701
  • [49] A Novel Antitumor Prodrug Platform Designed to Be Cleaved by the Endoprotease Legumain
    Stern, Liron
    Perry, Rotem
    Ofek, Paula
    Many, Ariel
    Shabat, Doron
    Satchi-Fainaro, Ronit
    BIOCONJUGATE CHEMISTRY, 2009, 20 (03) : 500 - 510
  • [50] Antitumor and antiangiogenic activities of Ro 28-2653, a synthetic matrix metalloproteinase inhibitor.
    Noel, A
    Maquoi, E
    Devy, L
    Olivier, F
    Roland, G
    Tiefenthaler, G
    Krell, HW
    Foidart, JM
    CLINICAL CANCER RESEARCH, 2000, 6 : 4524S - 4524S